© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Blue Water Vaccines, Inc. (BWV) stock declined over -6.97%, trading at $0.18 on NASDAQ, down from the previous close of $0.19. The stock opened at $0.20, fluctuating between $0.18 and $0.20 in the recent session.
Blue Water Vaccines, Inc., a biotechnology company, engages in the research and development of vaccines to prevent infectious diseases worldwide. The company's lead vaccine programs that are under preclinical development include BWV-101, an influenza vaccine; and BWV-102, a H1 pre-pandemic vaccine. It also has other pipeline under preclinical development comprising BWV-201, a streptococcus pneumoniae induced acute otitis media vaccine program; BWV-301, a norovirus-rotavirus vaccine program; and BWV-302, a norovirus-malaria vaccine program. The company was incorporated in 2018 and is based in Cincinnati, Ohio.
Employees | 12 |
Beta | 0 |
Sales or Revenue | $0.00 |
5Y Sales Change% | 0% |
Fiscal Year Ends | December |
Sector | Healthcare |
Industry | Biotechnology |
Blue Water Vaccines, Inc. (NASDAQ: BWV) stock price is $0.18 in the last trading session. During the trading session, BWV stock reached the peak price of $0.20 while $0.18 was the lowest point it dropped to. The percentage change in BWV stock occurred in the recent session was -6.97% while the dollar amount for the price change in BWV stock was -$0.01.
The NASDAQ listed BWV is part of Biotechnology industry that operates in the broader Healthcare sector. Blue Water Vaccines, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Dr. Brian Price Ph.D.
Head of Technology Strategy
Dr. Ronald R. Cobb Ph.D.
Head of Science & Discovery
Mr. Jon M. Garfield
Chief Financial Officer
Dr. Ali I. Fattom Ph.D.
Head of Science & Discovery
Mr. Theodore Scott Yoho
Head of Bus. Devel.
Mr. Frank A. Jaeger M.A., M.B.A.
Senior Vice President of Marketing & Bus. Devel.
Ms. Erin Henderson
Chief Bus. Officer & Corporation Sec.
Mr. Andrew D. Skibo Ph.D.
Global Head of Biologics Operations
Mr. Joseph Hernandez M.S., MBA
Chief Executive Officer, Pres & Executive Chairman
BWV's closing price is 12.55% higher than its 52-week low of $0.16 where as its distance from 52-week high of $1.95 is -90.76%.
Number of BWV employees currently stands at 12.
Official Website of BWV is: https://www.bluewatervaccines.com
BWV could be contacted at phone 513 620 4101 and can also be accessed through its website. BWV operates from 201 East Fifth Street, Cincinnati, OH 45202, United States.
BWV stock volume for the day was 520.29K shares. The average number of BWV shares traded daily for last 3 months was 435.53K.
The market value of BWV currently stands at $3.41M with its latest stock price at $0.18 and 18.9M of its shares outstanding.